BibTex RIS Cite

Immune hemolytic anemia with visceral leishmaniasis

Year 2014, Volume: 3 Issue: 1, 84 - 87, 01.01.2014
https://doi.org/10.5505/abantmedj.2014.92486

Abstract

Visceral leishmaniasis kala-azar , caused by protozoan parasites, is a chronic infectious disease characterized by fever, weight loss, pallor, hypergammaglobulinemia, enlargement of spleen and liver, and pancytopenia. It is an endemic disease in all Mediterranean countries including Turkey and the children are at higher risk than adults. In this disease, anemia is the most common hematological manifestation and appears to be due to many factors but the immune hemolytic anemia has been seen rarely. In this report, we presented a 2 year old child applied to our hospital with fever, splenomegaly and immune hemolytic anemia. The hematological improvement was noted after meglumin antimonate therapy within 1-2 weeks.

References

  • Özbel Y, Töz ÖS, Leishmaniosis, Özcel MA. Tıbbi Parazit Hastalıkları 1. Baskı, İzmir: Mete Basım Matbaacılık Hizmetleri, 2007: 198-230.
  • Reithinger R, Dujardin JC. Molecular Diagnosis of Leishmaniasis: Current Status and Future Applications. J Clin Microbiol 2007: 21- 5.
  • Varma N, Naseem S. Hematologic Changes in Visceral Leishmaniasis/Kala Azar. Indian J Hematol Blood Transfus. 2010;26:78–82.
  • WHO Technical Report Series: 949, Control of the Leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22–26 March 2010.
  • Vilela RB, Bordin JO, Chiba AK, Castelo A, Barbosa MC. RBC-associated IgG in patients with visceral leishmaniasis (kala-azar): a
  • prospective analysis. Transfusion 2002; 42: 1442-7.
  • Çelik Ü, Leblebisatan G, Alhan E, Aksaray N. Immune hemolytic anemia in association with visceral leishmaniasis: Case report. J Pediatr Inf 2007;1:36-8.
  • Dilber E, Erduran E, Işık Y. Visceral leishmaniasis and Coombs’ positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B. Turk J Pediatr 2002; 44(4):354-6.
  • Ayyıldız Orhan. Leyişmanıyazis. 35.Ulusal Hematoloji Kongresi (7-10 Ekim 2009).

Visseral leishamniasisle beraber görülen immün hemolitik anemi

Year 2014, Volume: 3 Issue: 1, 84 - 87, 01.01.2014
https://doi.org/10.5505/abantmedj.2014.92486

Abstract

Visseral Leishmaniasis kala-azar , protozoan parazitlerin neden olduğu, ateş, kilo kaybı, solukluk, hipergamaglobulinemi, hepatosplenomegali, pansitopeni ile karakterize kronik enfeksiyöz bir hastalıktır. Tüm Akdeniz ülkelerinde endemik görülmektedir ve çocuklar erişkinlerden daha çok risk altındadır. Anemi en sık karşılaşılan hematolojik sorundur ve birçok faktöre bağlı olarak ortaya çıkmaktadır ancak immün hemolitik anemi nadir görülmektedir. Bu yazıda 2 yaşında ateş, splenomegali ve immün hemolitik anemi ile hastanemize başvuran hasta sunuldu. Hastada, meglumin antimon tedavi sonrası 1-2 hafta içinde hematolojik düzelme gözlendi.

References

  • Özbel Y, Töz ÖS, Leishmaniosis, Özcel MA. Tıbbi Parazit Hastalıkları 1. Baskı, İzmir: Mete Basım Matbaacılık Hizmetleri, 2007: 198-230.
  • Reithinger R, Dujardin JC. Molecular Diagnosis of Leishmaniasis: Current Status and Future Applications. J Clin Microbiol 2007: 21- 5.
  • Varma N, Naseem S. Hematologic Changes in Visceral Leishmaniasis/Kala Azar. Indian J Hematol Blood Transfus. 2010;26:78–82.
  • WHO Technical Report Series: 949, Control of the Leishmaniases. Report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22–26 March 2010.
  • Vilela RB, Bordin JO, Chiba AK, Castelo A, Barbosa MC. RBC-associated IgG in patients with visceral leishmaniasis (kala-azar): a
  • prospective analysis. Transfusion 2002; 42: 1442-7.
  • Çelik Ü, Leblebisatan G, Alhan E, Aksaray N. Immune hemolytic anemia in association with visceral leishmaniasis: Case report. J Pediatr Inf 2007;1:36-8.
  • Dilber E, Erduran E, Işık Y. Visceral leishmaniasis and Coombs’ positive hemolytic anemia: a rare association in an infant treated with liposomal amphotericin B. Turk J Pediatr 2002; 44(4):354-6.
  • Ayyıldız Orhan. Leyişmanıyazis. 35.Ulusal Hematoloji Kongresi (7-10 Ekim 2009).
There are 9 citations in total.

Details

Primary Language Turkish
Journal Section Research Article
Authors

Özlem Gül This is me

Yalçın Göksügür This is me

Mehmet Davutoğlu This is me

Mesut Garipardıç This is me

Publication Date January 1, 2014
Published in Issue Year 2014 Volume: 3 Issue: 1

Cite

APA Gül, Ö., Göksügür, Y., Davutoğlu, M., Garipardıç, M. (2014). Visseral leishamniasisle beraber görülen immün hemolitik anemi. Abant Medical Journal, 3(1), 84-87. https://doi.org/10.5505/abantmedj.2014.92486
AMA Gül Ö, Göksügür Y, Davutoğlu M, Garipardıç M. Visseral leishamniasisle beraber görülen immün hemolitik anemi. Abant Med J. January 2014;3(1):84-87. doi:10.5505/abantmedj.2014.92486
Chicago Gül, Özlem, Yalçın Göksügür, Mehmet Davutoğlu, and Mesut Garipardıç. “Visseral Leishamniasisle Beraber görülen immün Hemolitik Anemi”. Abant Medical Journal 3, no. 1 (January 2014): 84-87. https://doi.org/10.5505/abantmedj.2014.92486.
EndNote Gül Ö, Göksügür Y, Davutoğlu M, Garipardıç M (January 1, 2014) Visseral leishamniasisle beraber görülen immün hemolitik anemi. Abant Medical Journal 3 1 84–87.
IEEE Ö. Gül, Y. Göksügür, M. Davutoğlu, and M. Garipardıç, “Visseral leishamniasisle beraber görülen immün hemolitik anemi”, Abant Med J, vol. 3, no. 1, pp. 84–87, 2014, doi: 10.5505/abantmedj.2014.92486.
ISNAD Gül, Özlem et al. “Visseral Leishamniasisle Beraber görülen immün Hemolitik Anemi”. Abant Medical Journal 3/1 (January 2014), 84-87. https://doi.org/10.5505/abantmedj.2014.92486.
JAMA Gül Ö, Göksügür Y, Davutoğlu M, Garipardıç M. Visseral leishamniasisle beraber görülen immün hemolitik anemi. Abant Med J. 2014;3:84–87.
MLA Gül, Özlem et al. “Visseral Leishamniasisle Beraber görülen immün Hemolitik Anemi”. Abant Medical Journal, vol. 3, no. 1, 2014, pp. 84-87, doi:10.5505/abantmedj.2014.92486.
Vancouver Gül Ö, Göksügür Y, Davutoğlu M, Garipardıç M. Visseral leishamniasisle beraber görülen immün hemolitik anemi. Abant Med J. 2014;3(1):84-7.